Ìý NEWS ARCHIVE


Jupiter Presents Award-Winning Author

By | September 26, 2016

Jupiter LLS and Honors College Presents Author Edwidge Danticat

Worm Holds Key to Treating Epilepsy and Rapid Drug Discovery

By | September 26, 2016

Researchers from Â鶹ŮÀÉ, in collaboration with The Scripps Research Institute, have opened up the possibilities for rapid drug screens to treat seizures in the near future by using a microscopic nematode worm.

Max Planck-Â鶹ŮÀÉ Premier Doctoral Program

By | September 22, 2016

The nation's first International Max Planck Research School (IMPRS) for Brain and Behavior via Â鶹ŮÀÉ collaboration launched this fall semester with five students from Â鶹ŮÀÉ.

Â鶹ŮÀÉ Jupiter's LLS Announces Fall Schedule

By | August 1, 2016

Â鶹ŮÀÉ has announced the Lifelong Learning Society Jupiter course offerings for the fall semester, which begins Monday, Oct. 10.

New Dean of Harriet L. Wilkes Honors College

By | June 20, 2016

Â鶹ŮÀÉ has appointed Ellen S. Goldey, Ph.D., as the new dean of the Harriet L. Wilkes Honors College, effective Monday, Aug. 1.

Â鶹ŮÀÉ and Town of Jupiter Celebrate Arbor Day

By | May 11, 2016

Â鶹ŮÀÉ and Town of Jupiter officials recently celebrated Arbor Day and Honored Former Jupiter Mayor in the Robert J. Huckshorn Arboretum on Â鶹ŮÀÉ's John D. MacArthur Campus in Jupiter.

Renowned Neuroscientist to Lead Â鶹ŮÀÉ's New Brain Institute

By | May 10, 2016

Randy D. Blakely, Ph.D., a renowned neuroscientist and leading expert in synaptic pharmacology, neurotransmitter transporters, and neurogenetics, is at the helm of the newly-formed Â鶹ŮÀÉ Brain Institute.

First Graduate of Â鶹ŮÀÉ-Max Planck Degree Program

By | May 3, 2016

Brati Das, 32, recently became the first student approved to graduate with Â鶹ŮÀÉ's Integrative Biology and Neuroscience (IBAN) degree.

Â鶹ŮÀÉ Jupiter's LLS Awards $11,000 in Scholarships

By | April 25, 2016

Â鶹ŮÀÉ Jupiter's LLS awarded 11 scholarships to undergraduate and graduate students.

Researcher Receives NIH Grant for MS and Cancer Treatment

By | April 19, 2016

A leading scientist has received $540,250 from the NIH to continue his groundbreaking research to develop new therapeutic agents for collagen-based diseases including multiple sclerosis, cancer and sepsis.

Ìý